Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:32 AM
Ignite Modification Date:
2025-12-25 @ 4:32 AM
NCT ID:
NCT02677818
Eligibility Criteria:
Inclusion Criteria:
* Guidelines prepared by the diagnostic criteria(according to the diagnostic criteria of the Fourth National Stroke Conference prepared,have been more than one times skull CT and/or MRI)was confirmed for ischemic stroke,and requires the use of antithrombotic therapy(including thrombolysis, anticoagulation, antiplatelet) patients
* Willing and able to comply with the study protocol and visits planned
Exclusion Criteria:
* At the same time the presence of other active malignancy.
* There is known brain metastases or leptomeningeal metastases
* Systemic active infection ( ie infection leads to body temperature ≥38 ℃)
* The last 4 weeks there is a need drainage ascites, pleural effusion or pericardial fluid .
* Clinically significant obstruction , pulmonary fibrosis , kidney failure , liver failure and other diseases.
* Uncontrolled diabetes.
* Severe / unstable angina, New York Heart Association (NYHA) class III or IV symptoms of congestive heart failure
* there is other reason (not the antithrombotic drugs) caused by bleeding.
* The presence of an autoimmune disease or a history of organ transplant patients require immunosuppressive therapy
* Psychiatric presence may increase the risks associated with study participation or study drug , or may interfere with the interpretation of study results
* Pregnant and lactating women
* Bleeding disorders may exist on admission
* The researchers added that the study is not appropriate to the circumstances
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
30 Years
Maximum Age:
65 Years
Study:
NCT02677818
Study Brief:
Protocol Section:
NCT02677818